Padmaja Subbarao

From Wikipedia, the free encyclopedia
Padmaja Subbarao
Academic background
EducationB.Sc., Biology, 1990, University of Ottawa
MD, 1994, University of Toronto Faculty of Medicine
M.Sc. Epidemiology, 2002, McMaster University
Academic work
InstitutionsUniversity of Toronto
McMaster University

Padmaja (PJ) Subbarao is a Canadian respirologist and scientist in physiology and experimental medicine. She is a Tier 1 Canada Research Chair in Pediatric Asthma and Lung Health at the University of Toronto and the Associate Chief of Clinical Research at SickKids Hospital.

Early life and education[edit]

Subbarao completed her Bachelor of Science degree at the University of Ottawa before enrolling at the University of Toronto Faculty of Medicine for her medical degree. Upon earning her MD in 1994, Subbarao completed her residency at the Children's Hospital of Eastern Ontario and her fellowship at SickKids Hospital. Following her residency, Subbarao was accepted to McMaster University for her Master of Science degree in epidemiology.[1]

Career[edit]

Upon receiving her Master of Science degree in 2002, Subbarao began a research fellowship with the Canadian Lung Association and the Canadian Institutes of Health.[1] She then joined the Canadian Healthy Infant Longitudinal Development (CHILD) Study established by Malcolm Sears to "investigate the genetic and environmental determinants of atopic diseases including asthma, allergy, allergic rhinitis, and eczema."[2] By 2010, the CHILD study had registered 1,200 kids at birth with the intent to follow them for five years to look for the causes of asthma and allergies right from pregnancy.[3] In 2013, Subbarao received the Breathe New Life Award from The Lung Health Foundation to fund her project; "Development of novel clinical tests to diagnose and monitor asthma in preschool children."[4] As a member of the CHILD Study, Subbarao developed the use of novel early life lung function tools as objective measures of the onset of lung disease and established the first infant lung function laboratory in Canada.[5]

Prior to the 2015–16 academic year, Subbarao accepted a cross-appointee in physiology at the University of Toronto.[6] She also received the Canadian Institutes of Health Research New Investigator Salary Award for Clinical Research in cohort study and pulmonary physiology measurements.[7] In January 2020, Subbarao received an award from the Canadian Microbiome Initiative 2 program to allow the CHILD Cohort Study researchers to better understand the role of the microbiome in human health and disease.[8] Towards the end of the year, Subbarao and David Malkin were named leaders of the Precision Child Health initiative at Sick Kids Hospital.[9]

In June 2021, Subbarao was awarded a Tier 1 Canada Research Chair in Pediatric Asthma and Lung Health to support her research.[5] She also oversaw the launch of the CHILD COVID-19 Rapid Results webpage to illustrate how the pandemic was affecting the physical and mental health of Canadian families.[10] In March 2022, Subbarao was honoured with the Michelle Harkness Mentorship Award from the Allergy, Genes and Environment Network for mentoring excellence by an established academic researcher.[11]

References[edit]

  1. ^ a b "Padmaja Subbarao". Sick Kids. Retrieved December 27, 2022.
  2. ^ Dinshaw, Fram (November 3, 2022). "McMaster allergy institute supports leading Canadian CHILD study". McMaster University. Retrieved December 27, 2022.
  3. ^ "Asthma among kids hits lowest level in decade". Red Deer Advocate. November 19, 2010. Retrieved December 27, 2022 – via newspapers.com.
  4. ^ "Breathe New Life Award". The Lung Health Foundation. Retrieved December 27, 2022.
  5. ^ a b Beck, Marshall (June 15, 2021). "CHILD Director awarded prestigious Tier 1 Canada Research Chair". The Allergy, Genes and Environment Network. Retrieved December 27, 2022.
  6. ^ "NEW CROSS-APPOINTEE". University of Toronto. September 11, 2015. Retrieved December 27, 2022.
  7. ^ Mitchell, Liam (April 29, 2016). "U of T researchers to investigate environment's health impact". University of Toronto. Retrieved December 27, 2022.
  8. ^ "CHILD Cohort Study researchers awarded $2M to study microbial causes of asthma". Children's Hospital Research Institute of Manitoba. January 31, 2020. Retrieved December 27, 2022.
  9. ^ Beck, Marshall (November 12, 2020). "CHILD Director & Co-Director lead major precision health initiatives". The Allergy, Genes and Environment Network. Retrieved December 27, 2022.
  10. ^ "CHILD Cohort Study releases new COVID-19 Rapid Results data". CHILD Study. June 21, 2021. Retrieved December 27, 2022.
  11. ^ "CHILD's Director receives mentorship award". CHILD Study. March 7, 2022. Retrieved December 27, 2022.

External links[edit]